Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

MYLAN LABORATORIES INC — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Report

MYLAN LABORATORIES INC

via GILBERT'S LLP

4th Quarter (Oct 1 - Dec 31) · 2012Posted Jan 21, 2013Filing document ↗LDA record ↗

Income$38Kfee reported

Client

Name: MYLAN LABORATORIES INC
Location: Pennsylvania · United States of America

Registrant

Firm: GILBERT'S LLP
Location: TORONTO, ON, Canada

Lobbying activities

1 issue

Health Issues
Reform to legislation and regulations affecting pharmaceutical approvals and related patent issues.
Lobbyistsmr TIM GILBERT

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.